Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of a new Lassa virus vaccine in healthy volunteers
PACTR202108781239363Phase 1Completed
- Sponsor
- Emergent BioSolutions
- Start
- Mar 2022
- Countries
- 1
01
Overview
Phase 1 trial in Lassa fever, sponsored by Emergent BioSolutions. Started Mar 2022; status: completed.
02
Conditions
Lassa fever
Beyond the preview
Go deeper on PACTR202108781239363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202108781239363.